This ones a heck of a specualive investment but it seems that the institutions are willing to stomp up the cash to back it in the long term.

Heres the latest news from Killik stocbrokers on the company..........

MEDICAL MARKETING Joint Venture

We recently highlighted Medical Marketing (MMG) as worthy of attention. The company, in which I have a personal share holding, has this morning announced the formation of a joint venture, Genvax, to develop a novel DNA vaccine platform technology.

Human trials have been underway since 2001 in areas such as Lymphoma and Myeloma but the technology has broad applications in cancer, viral and bacterial infections (hence the term platform). The technology works on boosting the immune system by teaching it to identify hard to recognise cancer proteins as foreign and destroy them. Early results from the 25 patient trial in lymphoma are encouraging and evaluation of the result is expected by March 2005. Successful results should mean big pharmaceutical groups will start to take financial and commercial interests around that time.

This looks to be the first of a series of announcements due from Medical Marketing as it has a range of predominantly cancer trials moving into the clinical stage. (news flow could push the price higher)

The stock has made good progress in recent sessions up to the mid-80p level where the company is valued at just under 40 million. ENDS.

Please DYOR

cheers GF.

This is to be avoided...sp moving downwards by the day.

I was in 2 years ago at 50-80p and took profits when it hit a ridiculous 280p.
Had a dabble agian after cash was raised at 120p and sold at 180p and been on watchlist ever since. There seems to be a large potential and I expect once all is clear with what is going on there will be a chance for both trading and investing profits to be made.

Agree
This has fallen from 150p to 4p in the past and revovered rapidly.
When dust settles and when appetite develops again for Biotech stocks it could happen again.
It may take some time but its definitely one to be watched again very closely.

There are after all 3 potential blockbusters in pipeline and the technology is not where the failure has been.

Well should it fall back to 3p I'm in again caesar but not before.

20p now...3p coming soon, mitzy

Its a shame hlyeo but 3p is about the size of it.

I think 3p is a bit pessimistic!!! they still have the 3 products, and despite the management f~cking up the business side of the company (and there is no doubt about that), the 3 treatments do still appear to be progressing, albeit slower than the deposed Best would have had us believe.
This might come good some day.....
For the record, I still hold a load of MMG shares. I know now this is blind stupidity rather than anything else!!

just a shame that best was the bullsh***er supreme
wether there is anything there of value must be open to doubt
rights issue coming? I would think that 10p might be a good price to raise at.

Management is always the ones that f#@k up companies, especially WNG, SEO and EME.

Your right notlob I admit DB took me for a fool and I fell for it the company is worthless thanks to him I should have known better than believe a bullshitter.

sorry to hear that, mitzy
guess he fooled lots of folks
didn't realise till recently that Best + his wife were oulling out a ftse100 salary between them (500K+)
Also, i think Best's wife was down as IT director, I mean, how much IT can there be in a company the size of MMI, certainly not the 200K or so she was pulling out the company.
I remember meeting Best quite a few years ago at an exhibition, he told be Cellfactors, at that time MMI owned a big chunk of them, would be ftse 100 in a few years, sadly they went bust and I lost a few bob on that one.

I met them a fw times and they were very convincing he said MMI was a 500 mill company in the making and now its worthless.

I got out of MMG at 110p. You can say David Best is a conman.

NeilMccloyd: - May I?
The "3-treatments" are (in reality) three Streams , = dreams - each becomming several "products", Each "product" requires a huge investment to get through trials/pass regulation/into sales.
- - - Oh, and finally they need a sales Partner. More pressing, they need CASH as well as a Parner to bankroll the PhaseIII trials in a few years time. Trials are notoriously expensive (something like $20m, but it could be pounds, the number is so big). Plus "time" - I recall Oxford Bio took 10-years and not one product is through!(Although OXB has not had any serious setbacks)
MMI is certainly "interesting" - but that is all - yes I agree the Salary looks very steep, esp. in view of their cash position (= under 10m, probably as low as 1m)

So where does that leave the value to shareholders, who are unlikely to want ( or be able), to cough up 20m for each product -
Dunno - for whichever product they go with, there are risks and the one product you can't make is "time" - that's what they ran out of - had they had more time (before the bubble burst) they would still be here, telling everyone it's worth 's.
Well, it ain't - the issue (now), is what is anyone prepared to invest? Would shareholders cough up 50p/share (to raise 20m-ish).....anyone that holds say 5k-worth at 1 =5000 will have lost 4k(today), yet need to find about 2500 -
Could investors be willing......? Maybe under certain conditions, like the Management is Bio-background and is rewarded as the Trials go forward, with the enphasis on keeping cash-spend low. The past-management is no longer an issue - they have no place IMHO, moving the company into the Medico Trials Arena.

Were there tell-tale signs?
1) The company name was a bit OTT, considering they didn't sell anything.
2) They didn't invent the products - they have some arrangement with a University, which is far from made clear
3) In nearly 8-years no phase trials had been concluded, nor a partner found for products that were (told to punters), world-class life-enhancing curatives.
(DYOR - anyone disagree?)

Anyone here, willing to invest ots to resolve [MMG] funding?
I wonder.
(or-= alternative views!)

So there it is DB and MM both sacked and the sp recovers where do we go from here.

The 2 wasters of MMG will be terminated...may their souls rest in peace!

Free section Michael Walters - 'The Battle for MMG'

http://www.michaelwalters.com/stories/news.phtml?num=3145

Sp rising, as earlier investors average down - but I suspect we'll see a massive placing and the spectre of Bankers taking a big chunk; such was the cash mis-management by The Fallen.
Of course it could have all been different, if Money-markets were like three years ago - that was the time when they should have taken whatever they could, but I suspect Execs didn't like the Terms.
Meanwhile the storm-clouds gathered as Money became tight, even though the limited Trials were on-going. However, their trials are not far-enough along to create real value, er IMHO.
Meeting 15 April 08 should be "exciting"

Good riddance to these two tossers...


Medical Marketing says directors David Best, Margaret Mitchell resign - AFX

LONDON (Thomson Financial) - Life sciences company Medical Marketing International Group PLC. said the company's founders, David Best and Margaret Mitchell, resigned as directors of the company with immediate effect, on April 14.

A meeting had been convened for Tuesday which would have proposed Best and Mitchell's removal.

Last month Medical Marketing International's new non-executive chairman Phil Cartmell announced that along with the company's board he had terminated the contract of managing director David best, and his wife, IT director Margaret Mitchell.

Best, who was on long-term sick leave with his wife, was the target of a shareholder-backed boardroom coup in February after institutional shareholders and board members appointed Cartmell to examine the make-up of the board and resolve a leadership dispute.

At the end of the company's financial year 2007, Best, who was also the former chairman of the company, and his wife owned between them 32.63 pct of the company.

tf.TFN-Europe_newsdesk@thomson.com

slm

Yes Meeting was exciting alright.